ABSTRACT Introduction: Pulmonary artery denervation (PADN) can reduce the sympathetic nervous system (SNS) activity, reduce pulmonary artery pressure (PAP), and improve the quality of life in patients
BackgroundAccording to several treatment guidelines, epoprostenol is an important treatment option for pulmonary arterial hypertension. However, the pharmacokinetic characteristics and poor stability
This was a retrospective cohort study of 59 consecutive children (aged 2–18 years) with a diagnosis of severe PAH-CHD secondary to a simple shunt defect, who underwent surgical repair for CHD, with or
